<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00006346</url>
  </required_header>
  <id_info>
    <org_study_id>SJHCH-TM1</org_study_id>
    <secondary_id>CDR0000068177</secondary_id>
    <secondary_id>NCI-V00-1618</secondary_id>
    <nct_id>NCT00006346</nct_id>
  </id_info>
  <brief_title>Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer</brief_title>
  <official_title>Stress Reduction For Breast Cancer in Women 55 Years of Age or Older: Enhancing Quality of Life and Survival</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unity Health Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Transcendental meditation may be an effective way to decrease the amount of stress&#xD;
      in older women with breast cancer. It is not yet known if transcendental meditation is more&#xD;
      effective than basic breast cancer education in improving quality of life.&#xD;
&#xD;
      PURPOSE: This randomized clinical trialstudies stress reduction in improvingquality of life&#xD;
      in older women with stage II, stage III, or stage IV breast cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  Compare the effects of active stress reduction with transcendental meditation vs basic&#xD;
           breast cancer education on quality of life and survival time in older women with stage&#xD;
           II, III, or IV breast cancer.&#xD;
&#xD;
        -  Determine behavioral mechanisms that may mediate the effects of stress reduction on&#xD;
           survival in these patients.&#xD;
&#xD;
        -  Determine baseline variables that contribute to predicting survival time in these&#xD;
           patients.&#xD;
&#xD;
      OUTLINE: This is a randomized, single blind (to medical staff), multicenter study. Patients&#xD;
      are stratified according to age and participation in support groups. Patients with stage IV&#xD;
      disease are also stratified according to type of metastases (visceral vs non-visceral) and&#xD;
      timing of metastases (first diagnosis vs recurrence). Patients are randomized to 1 of 2&#xD;
      treatment arms.&#xD;
&#xD;
        -  Arm I: Patients receive usual medical care and instruction on stress reduction using&#xD;
           transcendental meditation (TM), which involves a standard 7-step course. Patients attend&#xD;
           training for approximately 1-1.5 hours per session for a total of 6 sessions over 1&#xD;
           week, while receiving usual medical care. Patients then practice TM twice a day for 20&#xD;
           minutes. Patients attend group meetings for approximately 90 minutes once or twice&#xD;
           monthly for 6 months to ensure proper technique and understanding.&#xD;
&#xD;
        -  Arm II: Patients receive usual medical care and basic literature on breast cancer.&#xD;
&#xD;
      Quality of life is assessed at baseline and then every 6 months for up to 3 years.&#xD;
&#xD;
      Patients are followed monthly for up to 2.5 years.&#xD;
&#xD;
      PROJECTED ACCRUAL: Approximately 166 patients (83 per treatment arm) will be accrued for this&#xD;
      study within 6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2000</start_date>
  <completion_date type="Actual">September 2003</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Breast Cancer</condition>
  <condition>Psychosocial Effects of Cancer and Its Treatment</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>psychosocial assessment and care</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Diagnosis of stage II, III, or IV breast cancer&#xD;
&#xD;
          -  No brain or CNS metastases&#xD;
&#xD;
          -  Hormone receptor status:&#xD;
&#xD;
               -  Not specified&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
        Age:&#xD;
&#xD;
          -  55 and over&#xD;
&#xD;
        Sex:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
        Menopausal status:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Performance status:&#xD;
&#xD;
          -  ECOG 0-2&#xD;
&#xD;
        Life expectancy:&#xD;
&#xD;
          -  More than 3 months&#xD;
&#xD;
        Hematopoietic:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hepatic:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Renal:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Other:&#xD;
&#xD;
          -  No non-cancer life-threatening illness&#xD;
&#xD;
          -  No history of major psychiatric disorders&#xD;
&#xD;
          -  No drug abuse dependency disorder&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
        Biologic therapy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Chemotherapy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Endocrine therapy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Radiotherapy:&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Surgery:&#xD;
&#xD;
          -  Not specified&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rhoda S. Pomerantz, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Unity Health Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Joseph Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60657</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hope Center</name>
      <address>
        <city>Terre Haute</city>
        <state>Indiana</state>
        <zip>47809</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maharishi International University</name>
      <address>
        <city>Fairfield</city>
        <state>Iowa</state>
        <zip>52557</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Nidich SI, Fields JZ, Rainforth MV, Pomerantz R, Cella D, Kristeller J, Salerno JW, Schneider RH. A randomized controlled trial of the effects of transcendental meditation on quality of life in older breast cancer patients. Integr Cancer Ther. 2009 Sep;8(3):228-34. doi: 10.1177/1534735409343000.</citation>
    <PMID>19815592</PMID>
  </results_reference>
  <verification_date>March 2010</verification_date>
  <study_first_submitted>October 4, 2000</study_first_submitted>
  <study_first_submitted_qc>September 3, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2003</study_first_posted>
  <last_update_submitted>July 9, 2013</last_update_submitted>
  <last_update_submitted_qc>July 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2013</last_update_posted>
  <keyword>stage II breast cancer</keyword>
  <keyword>stage IV breast cancer</keyword>
  <keyword>stage IIIA breast cancer</keyword>
  <keyword>stage IIIB breast cancer</keyword>
  <keyword>psychosocial effects of cancer and its treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

